BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 17 filers reported holding BIOMX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,219 | -50.2% | 23,350 | -49.1% | 0.00% | – |
| Q2 2023 | $16,506 | +164960.0% | 45,850 | +37.8% | 0.00% | – |
| Q1 2023 | $10 | -80.4% | 33,266 | -87.7% | 0.00% | – |
| Q4 2022 | $51 | -99.8% | 270,848 | +208.6% | 0.00% | – |
| Q3 2022 | $30,000 | -48.3% | 87,757 | +11.2% | 0.00% | – |
| Q2 2022 | $58,000 | -69.1% | 78,933 | -18.9% | 0.00% | – |
| Q1 2022 | $188,000 | -27.1% | 97,355 | -39.6% | 0.00% | – |
| Q4 2021 | $258,000 | -71.4% | 161,114 | -45.4% | 0.00% | -100.0% |
| Q3 2021 | $903,000 | -61.3% | 295,175 | -31.0% | 0.00% | 0.0% |
| Q2 2021 | $2,335,000 | -27.8% | 427,702 | -5.9% | 0.00% | -50.0% |
| Q1 2021 | $3,235,000 | +10.2% | 454,377 | -1.2% | 0.00% | 0.0% |
| Q4 2020 | $2,935,000 | +11.5% | 460,047 | +10.8% | 0.00% | -33.3% |
| Q3 2020 | $2,633,000 | +61.3% | 415,296 | +40.5% | 0.00% | +50.0% |
| Q2 2020 | $1,632,000 | +54.4% | 295,615 | +95.8% | 0.00% | 0.0% |
| Q1 2020 | $1,057,000 | – | 150,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,133,402 | $11,648,000 | 1.19% |
| MMCAP International Inc. SPC | 684,451 | $3,737,000 | 0.18% |
| Orbimed Advisors | 2,313,489 | $12,632,000 | 0.13% |
| Taylor Wealth Management Partners | 31,804 | $174,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,207 | $78,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 359,000 | $1,960,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 104,000 | $568,000 | 0.01% |
| J. Goldman & Co LP | 150,000 | $92,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 427,702 | $2,335,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,060 | $6,000 | 0.00% |